Beijing Nuobote Biotech Co., Ltd. announced that it will receive CNY 56,000,000 in an equity round of funding on April 26, 2022. The transaction will include participation from returning investor, Meek Technology Development Co.,Ltd. to maintain its 100% stake in the company. Post the closing, the registered capital of the company will increase from CNY 542.31 million to CNY 598.31 million.

The transaction has been approved at the 33rd session of the investor's 2nd directorate and the 19th session of the company's 2nd supervisory board. The transaction is still subject to approval from its investor's 1st special shareholder's meeting for 2022.